GSK-J4 |
GSK-J4 : Inhibitor Prodrug of KDM6A and KDM6B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KDM6A | ||
| KDM6B |
|
|
Prodrug
1 nM - 5 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - KDM5B 950 nM, KDM5C 1760 nM
Potency Assay Off-Target:
Inactive against additional demethylases in thermal shift, MS and antibody-based assays
Selectivity Assessment Description:
Inactive against additional demethylases in thermal shift, MS and antibody-based assays. GSK-J1 had ...
Potency Cellular
In Vitro
KDM6A
Mode of Action: Prodrug
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature11262
KDM6B
Mode of Action: Prodrug
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature11262
Negative Control Compounds
Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-3-yl)pyrimidin-4-yl)amino)propanoate
Chemical Information
| Molecular Formula | C24H27N5O2 |
| SMILEs | CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1 |
| InChI | InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28) |
| Molecular weight | 417.22 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 58 |
References
Publications
Vendors
- Abcam (1373423-53-0)
- Cayman (1797983-09-5)
- MCULE
- MedChem Express (1373423-53-0)
- MilliporeSigma (1373423-53-0)
- Tocris (1227911-45-6)
Note: This is not an exhaustive list and does not indicate endorsement by the portal.